Cat. No. |
Product Name |
Information |
PC-35156 |
KNI-1657
HIV-1 protease inhibitor
|
KNI-1657 (KNI1657) is a highly potent HIV-1 protease inhibitor (97% inhibition at 1 nM) with high sensitivity against lopinavir/ritonavir- or darunavir-resistant strains. |
PC-43512 |
TAK-779
CCR5 antagonist
|
TAK-779 is a potent, specific, nonpeptide CCR5 antagonist with Kd of 0.45 nM, antagonizes CCR2b to a lesser extent (27 nM) but does not affect CCR1, CCR3, or CCR4. |
PC-43481 |
MK-2048
HIV-1 integrase inhibitor
|
MK-2048 is a potent inhibitor of HIV-1 integrase (IN) and IN mutant R263K with IC50 of 2.6 nM and 1.5 nM, respectively. |
PC-63542 |
PF-3450074
HIV capsid inhibitor
|
PF-3450074 (PF74) is a small molecule HIV capsid protein, destabilized the viral capsid in vitro. |
PC-63540 |
GS-9695
HIV integrase inhibitor
|
GS-9695 is a potent, non-catalytic site HIV integrase inhibitor with wild type EC50 of 1.2 nM. |
PC-63539 |
GS-9822
HIV integrase inhibitor
|
GS-9822 (GS9822) is a potent, non-catalytic site HIV integrase inhibitor with wild type EC50 of 3 nM, potently inhibits the LEDGF/p75-integrase interaction with IC50 of 70 nM. |
PC-43448 |
BMS-707035
|
BMS-707035 is a potent, specific, and reversible HIV-I integrase (IN) inhibitor that blocks HIV IN strand transfer activity with IC50 of 15 nM.. |
PC-63384 |
GSK2838232
HIV maturation inhibitor
|
GSK-2838232 is a novel HIV maturation inhibitor being developed for the treatment of HIV in combination with other antiretroviral therapy.. |
PC-43418 |
Dolutegravir sodium
HIV integrase inhibitor
|
Dolutegravir sodium (GSK1349572A) is a potent, next-generation HIV integrase (IN) inhibitor, inhibits HIV-1 integrase-catalyzed strand transfer with IC50 of 2.7 nM. |
PC-43417 |
Dolutegravir
HIV integrase inhibitor
|
Dolutegravir (GSK1349572) is a potent, next-generation HIV integrase (IN) inhibitor, inhibits HIV-1 integrase-catalyzed strand transfer with IC50 of 2.7 nM. |
PC-43335 |
HIV-1 integrase inhibitor TB11
HIV-1 integrase inhibitor
|
HIV-1 integrase inhibitor TB11 is a small molecule, aryl beta-diketo (ADK)-based HIV-1 integrase inhibitor with IC50 of 1.53 uM, anti-viral IC50 of 2.1 uM. |
PC-62902 |
IC-9564
HIV entry inhibitor
|
IC-9564 (AIDS033640) is a betulinic acid derivative and potent HIV entry inhibitor that blocks HIV-1 envelope-mediated membrane fusion with IC90 of 0.22 uM for NL4-3 strain. |